Hematopoietic Stem Cell Transplantation: Are We There Yet?
Poster Nov 08, 2014
Shalmali Pendse, Anuradha Vaidya
Hematopoietic stem cells (HSCs) have a remarkable potential to self-renew and differentiate into many blood cell types. Self-renewal is the property to retain the stem cell status following cell division whereas differentiation is the property to get committed to a more specific lineage. HSCs have been studied extensively for therapeutic purposes in the treatment of blood diseases, inherited blood disorders, and autoimmune diseases. Today hematopoietic stem cell transplantation (HSCT) is not only an established treatment for various malignant and non-malignant conditions, but it is the only acceptable therapeutic procedure using stem cells.
Thomas et al (1957) were the first to perform allogeneic HSCT to treat a patient suffering from a hematological malignancy. In 1968, severe combined immuno-deficient disease (SCID) patients treated with HSCT were the first reported long term survivors following transplantation using HSCs. The discovery by Till and McCulloch embarked on a new journey towards many investigations to clarify HSC biology, functional characterization, purification, cultivation and other aspects of stem cell research, and HSCT. Simultaneously, the use of various conditioning regimens prior to allogeneic HSCT also improved the probability of long-term remission.
Recently, the concept of using mesenchymal stem cells (MSCs) along with HSCs is becoming a promising factor in improving transplantation success rates. Furthermore, the identification of novel HSC specific markers has proved beneficial in selectively isolating and transplanting HSCs especially in allogeneic transplantation using bone marrow, thereby greatly reducing the chances of graft rejection.
In the poster review we will discuss the various advancements in HSC research and their contributions in improving HSCT outcomes.
Cerebral Malaria Insights: Pathogenesis, Host Parasite Interactions including Host ResistancePoster
Cerebral malaria is a dreadful disease transmitted by mosquito. The major preventive approach is focused more in vector control than development of anti-malarial drug. The purpose of this presentation is to analyze different aspects of disease manifestations including clinical symptoms and pathogenesis in the context of mosquito borne infections in different geographical regions of the world.READ MORE
Amoebic Meningoencephalitis: Etiology, Infection and PreventionPoster
The presentation covers the different types of organisms that can cause amoebic meningioencephalitis. The two main types focused on are primary amoebic meningioencephalitis and granulomatous amoebic meningioencephalitis. The method of transmission and target hosts are vastly different. Prevention of these diseases is imperfect at best, as complete avoidance is the only way to not contract the disease.READ MORE
Depressive Symptoms Related to Biological Markers of Immune Functioning among Young People with HIVPoster
Youth living with HIV (YLWH) are at risk for depression. This study aimed to identify trends in depressive symptoms for YLWH in a specialty-care clinic and follow up clinical treatment procedures.READ MORE